Fund shareholders of CytomX Therapeutics Inc
ISIN US23284F1057 · United States · LEI 5493004VW2FW0QLL3345
- Fund shareholders
- 77
- Of which ETFs
- 20 57 other funds
- Value held
- ≈ 203.2M $ 202.8M $ · 290K €
- Share of capital
- 20.2 % of 217.9M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 6,531,787 | 30.7M $ | 0.00 % | 3.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 4,511,036 | 21.2M $ | 0.29 % | 2.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 3,970,290 | 16.8M $ | 0.20 % | 1.82 % | as of Apr 30, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 3,400,000 | 18.3M $ | 0.29 % | 1.56 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 2,500,000 | 10.6M $ | 0.37 % | 1.15 % | as of Apr 30, 2026 ↗ |
| Fidelity Stock Selector Small Cap Fund Fidelity Capital Trust | 2,450,510 | 10.3M $ | 0.15 % | 1.12 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 2,229,051 | 9.4M $ | 0.49 % | 1.02 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,992,904 | 9.4M $ | 0.01 % | 0.91 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 1,988,030 | 8.4M $ | 0.20 % | 0.91 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Small Cap Opportunities Fund Fidelity Securities Fund | 1,736,495 | 7.3M $ | 0.15 % | 0.80 % | as of Apr 30, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 1,222,540 | 6.6M $ | 0.12 % | 0.56 % | as of Feb 28, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 1,000,000 | 4.7M $ | 0.02 % | 0.46 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 987,397 | 4.6M $ | 0.06 % | 0.45 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 900,000 | 4.2M $ | 0.27 % | 0.41 % | as of Mar 31, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 860,000 | 4M $ | 0.40 % | 0.39 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Small Cap Core Fund Fidelity Concord Street Trust | 778,800 | 3.3M $ | 0.20 % | 0.36 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 700,350 | 3.8M $ | 0.01 % | 0.32 % | as of Feb 28, 2026 ↗ |
| First Trust Dow Jones Select MicroCap Index Fund First Trust Exchange-Traded Fund | 568,562 | 2.7M $ | 1.18 % | 0.26 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 453,100 | 2.4M $ | 0.00 % | 0.21 % | as of Feb 28, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 434,204 | 1.8M $ | 0.01 % | 0.20 % | as of Apr 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 371,652 | 2M $ | 0.01 % | 0.17 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 297,321 | 1.3M $ | 0.01 % | 0.14 % | as of Apr 30, 2026 ↗ |
| Fidelity Fundamental Small-Mid Cap ETF Fidelity Covington Trust | 290,427 | 1.2M $ | 0.09 % | 0.13 % | as of Apr 30, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 258,130 | 1.1M $ | 0.21 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 247,486 | 1.3M $ | 0.00 % | 0.11 % | as of Feb 28, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 228,039 | 962.3K $ | 0.60 % | 0.10 % | as of Apr 30, 2026 ↗ |
| VIP Stock Selector Portfolio Variable Insurance Products Fund | 218,000 | 1M $ | 0.02 % | 0.10 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 217,485 | 1M $ | 0.00 % | 0.10 % | as of Mar 31, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 208,397 | 879.4K $ | 0.00 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 195,100 | 1M $ | 0.00 % | 0.09 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 193,442 | 816.3K $ | 0.00 % | 0.09 % | as of Apr 30, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 184,201 | 777.3K $ | 0.01 % | 0.08 % | as of Apr 30, 2026 ↗ |
| U.S. Small Cap Growth Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 173,701 | 733K $ | 0.04 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 128,796 | 543.5K $ | 0.00 % | 0.06 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 115,646 | 543.5K $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 112,069 | 601.8K $ | 0.99 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 99,375 | 533.6K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 92,005 | 388.3K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 91,733 | 431.1K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS | 80,880 | 380.1K $ | 0.02 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 80,596 | 378.8K $ | 0.07 % | 0.04 % | as of Mar 31, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 79,888 | 337.1K $ | 0.18 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 74,256 | 313.4K $ | 0.01 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 71,243 | 300.6K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| WisdomTree U.S. SmallCap Fund WisdomTree Trust | 69,476 | 326.5K $ | 0.05 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 65,872 | 278K $ | 0.74 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 63,177 | 266.6K $ | 0.01 % | 0.03 % | as of Apr 30, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 60,806 | 285.8K $ | 0.02 % | 0.03 % | as of Mar 31, 2026 ↗ |
| U.S. VECTOR EQUITY PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 51,009 | 215.3K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 39,765 | 186.9K $ | 0.05 % | 0.02 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 37,337 | 175.5K $ | 0.02 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 36,564 | 154.3K $ | 0.01 % | 0.02 % | as of Apr 30, 2026 ↗ |
| SMALL COMPANY GROWTH PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS | 35,924 | 168.8K $ | 0.01 % | 0.02 % | as of Mar 31, 2026 ↗ |
| ACUITAS US MICROCAP FUND FORUM FUNDS II | 33,161 | 155.9K $ | 0.16 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 26,923 | 113.6K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 26,354 | 111.2K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 24,647 | 115.8K $ | 0.28 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 24,102 | 101.7K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Multi-Manager U.S. Small Cap Equity Fund Goldman Sachs Trust II | 23,675 | 99.9K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Formidable ETF ETF Opportunities Trust | 18,263 | 85.8K $ | 0.43 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 15,442 | 82.9K $ | 0.59 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 15,186 | 71.4K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 15,161 | 64K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 14,903 | 62.9K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 12,796 | 54K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares U.S. Tech Breakthrough Multisector ETF iShares Trust | 12,567 | 53K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 9,460 | 50.8K $ | 0.07 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 8,821 | 41.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 7,823 | 42K $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 7,723 | 32.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 5,200 | 24.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 2,765 | 13K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 1,429 | 6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 843 | 3.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 559 | 2.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Marketwide Value ETF Dimensional ETF Trust | 282 | 1.2K $ | 0.00 % | as of Apr 30, 2026 ↗ | |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 290K € | 0.35 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| First Trust Dow Jones Select MicroCap Index Fund First Trust Exchange-Traded Fund | 1.18 % | as of Mar 31, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 0.99 % | as of Feb 28, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.74 % | as of Apr 30, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 0.60 % | as of Apr 30, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.59 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 0.49 % | as of Apr 30, 2026 ↗ |
| Formidable ETF ETF Opportunities Trust | 0.43 % | as of Mar 31, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 0.40 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 0.37 % | as of Apr 30, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.35 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 76 | +12 | 44,092,939 | +18.4 % |
| 2026Q1 | 64 | +20 | 37,255,847 | +37.3 % |
| 2025Q4 | 44 | +12 | 27,133,848 | +26.5 % |
| 2025Q3 | 32 | +10 | 21,454,542 | +212.9 % |
| 2025Q2 | 22 | -3 | 6,856,745 | -4.9 % |
| 2025Q1 | 25 | -4 | 7,207,122 | +1.8 % |
| 2024Q4 | 29 | +2 | 7,081,811 | +6.6 % |
| 2024Q3 | 27 | 0 | 6,645,271 | +0.4 % |
| 2024Q2 | 27 | -3 | 6,615,762 | +12.0 % |
| 2024Q1 | 30 | -6 | 5,906,847 | -12.4 % |
| 2023Q4 | 36 | 6,741,826 |
Institutional managers
172 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 31,955,637 | 150.2M $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 15,013,093 | 70.6M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 10,202,785 | 48M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 10,098,824 | 47.5M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 9,982,124 | 46.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 7,875,390 | 37M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 5,663,408 | 26.6M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 5,406,193 | 25.4M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,228,280 | 24.6M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 4,975,826 | 23.4M $ | as of Mar 31, 2026 |
| Elmind Capital, LP | 4,550,000 | 21.4M $ | as of Mar 31, 2026 |
| Nextech Invest, Ltd. | 4,449,932 | 20.9M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 4,138,176 | 19.4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,660,190 | 17.2M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,582,985 | 16.8M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 3,457,711 | 16.3M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 3,410,190 | 16M $ | as of Mar 31, 2026 |
| Eversept Partners, LP | 3,188,514 | 15M $ | as of Mar 31, 2026 |
| UBS Group AG | 3,120,155 | 14.7M $ | as of Mar 31, 2026 |
| Jefferies Financial Group Inc. | 3,067,864 | 14.4M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 2,710,156 | 12.7M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 2,249,583 | 10.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,066,612 | 9.7M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 2,000,825 | 9.4M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,930,920 | 9.1M $ | as of Mar 31, 2026 |
Declared shareholders of CytomX Therapeutics Inc
6 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Longitude Capital Partners V, LLC and 5 others | 7.00 % | 15,288,461 | as of Mar 31, 2026 · SCHEDULE 13G |
| Kynam Capital Management, LP and 2 others | 6.90 % | 0 | as of Mar 31, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 5.00 % | 10,864,581 | as of Apr 15, 2026 · SCHEDULE 13G |
| Perceptive Advisors LLC and 2 others | 4.60 % | 10,098,824 | as of Mar 31, 2026 · SCHEDULE 13G |
| Venrock Healthcare Capital Partners III, L.P. and 6 others | 4.60 % | 9,982,124 | as of Mar 31, 2026 · SCHEDULE 13G |
| Seven Fleet Master Fund LP and 3 others | 0.50 % | 1,085,398 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of CytomX Therapeutics Inc". https://titelia.com/en/stocks/cytomx-therapeutics-inc-US23284F1057